Exosomes Derived from Human Mesenchymal Stem Cells Ameliorate Autistic-like Behaviors

Stem Cell Medicine Announces Late-Breaking News Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting JERUSALEM Israel, April 23, 2019 -- Stem Cell Medicine Ltd. (SCM), a biotechnology…

Continue Reading Exosomes Derived from Human Mesenchymal Stem Cells Ameliorate Autistic-like Behaviors

Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University

MSC-exo Technology Has Potential to Treat Autism Using Novel Intranasal AdministrationPreclinical Studies Have Demonstrated a Benefit on Core Autism SymptomsJERUSALEM Israel, January 2nd, 2019 -- Stem Cell Medicine Ltd. (SCM),…

Continue Reading Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University

Human Muscle Progenitor Cells Ectopically Expressing Neurotrophic Factors to Enhance Intrinsic Neuronal Regeneration

Stem Cell Medicine Ltd. (SCM), will present the results of a study titled “Human Muscle Progenitor Cells Ectopically Expressing Neurotrophic Factors Enhance Intrinsic Neuronal Regeneration in a Sciatic Nerve Injury Mouse Model".

Continue Reading Human Muscle Progenitor Cells Ectopically Expressing Neurotrophic Factors to Enhance Intrinsic Neuronal Regeneration

Stem Cell Medicine Signs License and Research Agreement with Ramot and Yeda to Develop Stem Cell-Based Treatments for Neuronal Diseases

Jerusalem, Israel, December 2, 2015 -- Stem Cell Medicine Ltd. (SCM), Ramot at Tel Aviv University Ltd. (Ramot), and Yeda Research and Development Company Ltd. (YEDA), announced today that they have entered into a license and research funding agreement...

Continue Reading Stem Cell Medicine Signs License and Research Agreement with Ramot and Yeda to Develop Stem Cell-Based Treatments for Neuronal Diseases